KIT and intrahepatic cholangiocarcinoma: The discovery of the tyrosine kinase receptor, C-kit, and its ligand, SCF, is critical in the development, maturation, and maintenance of the phenotype of ICC, which can be reliably identified by C-kit immunohistochemical techniques [21, 45, 46].